Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501000 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT07501000: Completed NA study, sponsored by Revision Skincare.
NCT07501000 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07501000, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun exposure, blemishes, and/or procedures when applied by a clinician in a series of 4 sessions at 2-week intervals. The procedure in this clinical study will include the brightening treatment, retinol serum, and a post-procedure cream. The study visits include baseline, week 2, 6, and 12.
Primary Outcome
The primary efficacy endpoint will be favorable analysis of the Investigator Clinical Grading of the appearance of global pigmentation due to sun exposure, blemishes, and/or procedures according to the Post-Inflammatory Hyperpigmentation Area and Severity Index (PIHASI) at weeks 2,4, 6, and 12 versus baseline. The PIHASI measures three pigment charactersitics: Darkness (Score 0 absent, 1 slight, 3 moderate, 4 maximum), Heterogeneity (Score 0 absent, 1 slight, 3 moderate, 4 maximum), and Area (sc
Interventions
- OTHER Brightening Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
What the finished NCT07501000 record still lists
NCT07501000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Brightening Treatment is the first listed.
NCT07501000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07501000 about?
NCT07501000 is a clinical study titled "Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen". A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun ...
What is the current status of trial NCT07501000?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-10-07. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT07501000?
The interventions under investigation include: Brightening Treatment (OTHER).
Who is sponsoring clinical trial NCT07501000?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07501000's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI